Schonfeld Strategic Advisors LLC - RUBIUS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Filings

EDGAR links

External links

Quarter-by-quarter ownership

Schonfeld Strategic Advisors LLC ownership history of RUBIUS THERAPEUTICS INC
	Value		Shares		Weighting
Q3 2022	$6,000	-57.1%	15,100	-3.8%	0.00%	–
Q2 2022	$14,000	-93.7%	15,700	+72.5%	0.00%	-100.0%
Q2 2021	$222,000	+117.6%	9,100	-55.2%	0.00%	0.0%
Q3 2020	$102,000	–	20,300	–	0.00%	–
Download

Other shareholders

RUBIUS THERAPEUTICS INC shareholders Q3 2021
Name	Shares	Value	Weighting ↓
Flagship Pioneering Inc.	38,506,526	$6,546,109	0.21%
HARBOURVEST PARTNERS LLC	986,878	$172,704	0.06%
Artal Group S.A.	2,042,666	$357	0.02%
Virtu Financial LLC	68,825	$12	0.00%
ACADIAN ASSET MANAGEMENT LLC	1,277,196	$222	0.00%
STATE OF MICHIGAN RETIREMENT SYSTEM	640,000	$110,144	0.00%
Baillie Gifford	4,869,126	$837,977	0.00%
Citadel Advisors	600	$103	0.00%
Tower Research Capital LLC (TRC)	25	$0	0.00%
JPMORGAN CHASE & CO	2,196	$0	0.00%

View complete list of RUBIUS THERAPEUTICS INC shareholders